Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase

References

• Acharya J, Rana H, Kaushik MP. (2011). Synthesis and in vitro evaluation of xylene linked carbamoyl bis-pyridinium monooximes as reactivators of organophosphorus (OP) inhibited electric eel acetylcholinesterase (AChE). Eur J Med Chem 46:3926–33
   PubMed Web of Science ®Google Scholar
• Aldridge WN, Reiner E. (1972). Enzyme inhibitors as substrates-inter actions of esterases with esters of organophosphorus and carba mic acids. Amsterdam: North-Hooland Publishing
   Google Scholar
• Artursson E, Akfur C, Hornberg A, et al. (2009). Reactivation of tabun hAChE investigated by structurally analogous oximes and mutagenesis. Toxicology 265:108–14
   PubMed Web of Science ®Google Scholar
• Aurbek N, Thiermann H, Szinicz L, et al. (2006). Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology 224:91–9
   PubMed Web of Science ®Google Scholar
• Bajgar J, Fusek J, Kuca K, et al. (2007). Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev Med Chem 7:461–6
   PubMed Web of Science ®Google Scholar
• Carey FA, Sundberg RJ. (2000). The structure and mechanisms. 4th ed. New York: Plenum Publishers, 13
   Google Scholar
• Dolgin E. (2013). Syrian gas attack reinforces need for better anti-sarin drugs. Nat Med 19:1194–5
   PubMed Web of Science ®Google Scholar
• Eddleston M, Buckley NA, Eyer P, Dawson AH. (2008). Management of acute organophosphorus pesticide poisoning. Lancet 371:597–607
   PubMed Web of Science ®Google Scholar
• Ekstrom F, Pang YP, Boman M, et al. (2006). Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol 72:597–607
   PubMed Web of Science ®Google Scholar
• Ghosh KK, Sinha D, Satnami ML, et al. (2005). Nucleophilic dephosphorylation of p-nitrophenyl diphenyl phosphate in cationic micellar media. Langmuir 21:8664–9
   PubMed Web of Science ®Google Scholar
• Gupta B, Ghosh KK. (2013). Evaluation of biological efficiency of oxime based reactivators against organophosphate inhibited AChE: an in-vitro study. Toxicol Lett 221:S147–8
   Web of Science ®Google Scholar
• Gupta B, Sharma R, Singh N, et al. (2014a). In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes. Arch Toxicol 88:381–90
   PubMed Web of Science ®Google Scholar
• Gupta B, Singh N, Sharma R, et al. (2014b). Assessment of antidotal efficacy of cholinesterase reactivators against paraoxon: in vitro reactivation kinetics and physicochemical properties. Bioorg Med Chem Lett 24:4743–8
   PubMed Web of Science ®Google Scholar
• Herkert NM, Lallement G, Clarencon D, et al. (2009). Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity. Toxicology 258:79–83
   PubMed Web of Science ®Google Scholar
• Horn G, Wille T, Musilek K, et al. (2015). Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase. Arch Toxicol 89:405–14
   PubMed Web of Science ®Google Scholar
• Jokanovic M, Prostran M. (2009). Pyridinium oximes as cholinester ase reactivators structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 1:2177–88
   Google Scholar
• Kassa J, Cabal J. (1999a). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111–18
   PubMed Web of Science ®Google Scholar
• Kassa J, Cabal J. (1999b). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol 18:560–5
   PubMed Web of Science ®Google Scholar
• Kassa J, Cabal J. (1999c). A comparison of the efficacy of Acetylcholinesterase reactivators against cyclohexylmethylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84:41–5
   PubMedGoogle Scholar
• Kuca K, Bartosova L, Jun D, et al. (2005). New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149:75–82
   PubMedGoogle Scholar
• Kuca K, Jun D, Musilek K. (2006). Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 6:269–77
   PubMed Web of Science ®Google Scholar
• Kuca K, Kassa J. (2003). A comparison of the ability of a new bispyridinium oxime – 1-(4-hydroxyiminomethylpyridinium-4-(4-carbamoylpy ridinium) butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem 18:529–35
   PubMed Web of Science ®Google Scholar
• Kwong TC. (2002). Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit 24:144–9
   PubMed Web of Science ®Google Scholar
• Luo C, Tong M, Chilukuri N, et al. (2007). An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes. Biochemistry 46:11771–9
   PubMed Web of Science ®Google Scholar
• Marrs TC. (1993). Organophosphate poisoning. Pharmacol Ther 58:51–66
   PubMed Web of Science ®Google Scholar
• Maxwell DM, Koplovitz I, Worek F, Sweeney RE. (2008). A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicol Appl Pharmacol 231:157–64
   PubMed Web of Science ®Google Scholar
• Mercey G, Verdelet T, Renou J, et al. (2012). Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res 45:756–66
   PubMed Web of Science ®Google Scholar
• Mercey G, Verdelet T, Saint-Andre G, et al. (2011). First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase. Chem Commun (Camb) 47:5295–7
   PubMed Web of Science ®Google Scholar
• Musilek K, Dolezal M, Gunn-Moore F, Kuca K. (2011). Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. Med Res Rev 31:548–75
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Jun D, et al. (2007a). Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker – preparation and reactivation of tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 15:6733–41
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Kuca K, et al. (2007b). Synthesis of a novel non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity using tabun and paraoxon-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 22:425–32
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Kuca K, et al. (2008). Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E) but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 23:70–6
   PubMed Web of Science ®Google Scholar
• Picha J, Kuca K, Kivala M, et al. (2005). A new group of monoquaternary reactivators of acetylcholinesterase inhibited by nerve agents. J Enzyme Inhib Med Chem 20:233–7
   PubMed Web of Science ®Google Scholar
• Sahu AK, Gupta B, Sharma R, et al. (2015). Kinetic and physicochemical analysis of structurally different bis-pyridinium oximes against pesticide inhibited AChE. Indian J Chem A 54A:40–5
   Google Scholar
• Saint-Andre G, Kliachyna M, Kodepelly S, et al. (2011). Design, synthesis, and evaluation of new alpha nucleophiles for the hydrolysis of organo-phosphorus nerve agents: application to the reactivation of phosphorylated AChE. Tetrahedron 67:6352–61
   Web of Science ®Google Scholar
• Sanson B, Nachon F, Colletier JP, et al. (2009). Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime. J Med Chem 52:7593–603
   PubMed Web of Science ®Google Scholar
• Sharma R, Ghosh KK. (2013). Kinetic Studies of Cholinesterase reactivators with organophosphate inhibited AChE. Toxicol Lett 221:S152–3
   PubMed Web of Science ®Google Scholar
• Sharma R, Gupta B, Acharya J, et al. (2014a). Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study. Toxicology 316:1–8
   PubMed Web of Science ®Google Scholar
• Sharma R, Gupta B, Singh N, et al. (2014b). Development and structural modifications of cholinesterase reactivators against chemical warfare agents in last decade: a review. Mini Rev Med Chem 15:58–72
   Web of Science ®Google Scholar
• Singh N, Karpichev Y, Gupta B, et al. (2013). Physicochemical properties and supernucleophilicity of oxime-functionalized surfactants: hydrolytic catalysts toward dephosphorylation of di- and triphosphate esters. J Phys Chem B 117:3806–17
   PubMed Web of Science ®Google Scholar
• Su CT, Wang PH, Lui RF, et al. (1986). Kinetic studies and structure-activity-relationships of bispyri dinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Fundam Appl Toxicol 6:506–14
   PubMedGoogle Scholar
• Verdelet T, Mercey G, Correa N, et al. (2011). Straight forward and efficient synthesis of 3-benzyloxy-4-bromopicolinate ester and 3-benzyloxy bromopicolinate ester, common building blocks for pharmaceuticals and agrochemicals. Tetrahedron 67:8757–62
   Web of Science ®Google Scholar
• Wang EIC, Braid PE. (1967). Oxime reactivation of diethylphosphoryl human serum cholinesterase. J Biol Chem 242:2683–7
   PubMed Web of Science ®Google Scholar
• Wiesner J, Kriz Z, Kuca K, et al. (2007). Acetylcholinesterases-the structural similarities and differences. J Enzyme Inhib Med Chem 22:417–24
   PubMed Web of Science ®Google Scholar
• Wong L, Radic Z, Bruggemann RJ, et al. (2000). Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis. Biochemistry 39:5750–7
   PubMed Web of Science ®Google Scholar
• Worek F, Aurbek N, Wetherell J, et al. (2008). Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase. Toxicology 244:35–41
   PubMed Web of Science ®Google Scholar
• Worek F, Aurbek N, Wille T, et al. (2011). Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and guinea pig acetylcholinesterase. Toxicol Lett 200:19–23
   PubMed Web of Science ®Google Scholar
• Worek F, Eyer P, Szinicz L. (1998). Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch Toxicol 72:580–7
   PubMed Web of Science ®Google Scholar
• Worek F, Mast U, Kiderlen D, et al. (1999). Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288:73–90
   PubMed Web of Science ®Google Scholar
• Worek F, Reiter G, Eyer P, Szinicz L. (2002). Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 76:523–9
   PubMed Web of Science ®Google Scholar
• Worek F, Thiermann H. (2013). The value of novel oximes for treatment of poisoning by organophosphorus compounds. Pharmacol Ther 139:249–59
   PubMed Web of Science ®Google Scholar
• Worek F, Thiermann H, Szinicz L, Eyer P. (2004). Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 68:2237–48
   PubMed Web of Science ®Google Scholar
• Worek F, Wellen J, von der, et al. (2012). Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent inhibited human acetylcholinesterase. Arch Toxicol 86:1379–86
   PubMed Web of Science ®Google Scholar